3 months compounded semaglutide Semaglutide for weight loss |

There are several safety issues related to unapproved versions of GLP-1s

Nausea is the most common side effect and up to 20% of people taking it for Type 2 diabetes reported nausea in clinical trials, according to GoodRx Health

Pregnant women exposed to these products and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500

Data from the FDA Adverse Event Reporting System (a database that reinforces continuous post-marketing surveillance to ensure drug safety) indicate a significant incidence of GI adverse effects in patients using semaglutide

Why Patients Quit: A Closer Look Cost & Insurance Many patients couldnt afford the medications or navigate insurance hurdles

4.9% placebo notably lower than TRIUMPH-4